Godkin A - Search Results

1

Expansion of hepatitis C-specific CD4+CD25+ regulatory T cells after viral clearance: a mechanism to limit collateral damage?

Godkin A, Ng WF, Gallagher K, Betts G, Thomas HC, Lechler RI. Godkin A, et al. J Allergy Clin Immunol. 2008 May;121(5):1277-1284.e3. doi: 10.1016/j.jaci.2008.01.070. Epub 2008 Mar 19. J Allergy Clin Immunol. 2008. PMID: 18355912

2

Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients.

Godkin A, Jeanguet N, Thursz M, Openshaw P, Thomas H. Godkin A, et al. Eur J Immunol. 2001 May;31(5):1438-46. doi: 10.1002/1521-4141(200105)31:5<1438::AID-IMMU1438>3.0.CO;2-2. Eur J Immunol. 2001. PMID: 11465100 Free article.

3

Evolution of epitope-specific memory CD4(+) T cells after clearance of hepatitis C virus.

Godkin AJ, Thomas HC, Openshaw PJ. Godkin AJ, et al. J Immunol. 2002 Aug 15;169(4):2210-4. doi: 10.4049/jimmunol.169.4.2210. J Immunol. 2002. PMID: 12165552

4

Immune tolerance to hepatitis C virus acquired during engraftment of bone marrow transplant.

Godkin A, Openshaw P, Thomas HC. Godkin A, et al. J Viral Hepat. 2005 Nov;12(6):604-8. doi: 10.1111/j.1365-2893.2005.00627.x. J Viral Hepat. 2005. PMID: 16255761

5

Regulating the immune response to tumours.

Betts GJ, Clarke SL, Richards HE, Godkin AJ, Gallimore AM. Betts GJ, et al. Adv Drug Deliv Rev. 2006 Oct 1;58(8):948-61. doi: 10.1016/j.addr.2006.05.006. Epub 2006 Aug 17. Adv Drug Deliv Rev. 2006. PMID: 17070961 Review.

6

CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer.

Clarke SL, Betts GJ, Plant A, Wright KL, El-Shanawany TM, Harrop R, Torkington J, Rees BI, Williams GT, Gallimore AM, Godkin AJ. Clarke SL, et al. Among authors: godkin aj. PLoS One. 2006 Dec 27;1(1):e129. doi: 10.1371/journal.pone.0000129. PLoS One. 2006. PMID: 17205133 Free PMC article.

7

Regulatory T cells inhibit Fas ligand-induced innate and adaptive tumour immunity.

Simon AK, Jones E, Richards H, Wright K, Betts G, Godkin A, Screaton G, Gallimore A. Simon AK, et al. Among authors: godkin a. Eur J Immunol. 2007 Mar;37(3):758-67. doi: 10.1002/eji.200636593. Eur J Immunol. 2007. PMID: 17294404 Free PMC article.

8

The impact of regulatory T cells on carcinogen-induced sarcogenesis.

Betts G, Twohig J, Van den Broek M, Sierro S, Godkin A, Gallimore A. Betts G, et al. Among authors: godkin a. Br J Cancer. 2007 Jun 18;96(12):1849-54. doi: 10.1038/sj.bjc.6603824. Epub 2007 Jun 12. Br J Cancer. 2007. PMID: 17565340 Free PMC article.

9

Interleukin-6 is crucial for recall of influenza-specific memory CD4 T cells.

Longhi MP, Wright K, Lauder SN, Nowell MA, Jones GW, Godkin AJ, Jones SA, Gallimore AM. Longhi MP, et al. Among authors: godkin aj. PLoS Pathog. 2008 Feb 29;4(2):e1000006. doi: 10.1371/journal.ppat.1000006. PLoS Pathog. 2008. PMID: 18389078 Free PMC article.

10

CD59 blockade enhances antigen-specific CD4+ T cell responses in humans: a new target for cancer immunotherapy?

Sivasankar B, Longhi MP, Gallagher KM, Betts GJ, Morgan BP, Godkin AJ, Gallimore AM. Sivasankar B, et al. J Immunol. 2009 May 1;182(9):5203-7. doi: 10.4049/jimmunol.0804243. J Immunol. 2009. PMID: 19380765 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters